The YAP/TEAD Axis as a New Therapeutic Target in Osteosarcoma: Effect of Verteporfin and CA3 on Primary Tumor Growth
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The YAP/TEAD Axis as a New Therapeutic Target in Osteosarcoma: Effect of Verteporfin and CA3 on Primary Tumor Growth
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 12, Pages 3847
Publisher
MDPI AG
Online
2020-12-21
DOI
10.3390/cancers12123847
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SHH Signaling Pathway Drives Pediatric Bone Sarcoma Progression
- (2020) Frédéric Lézot et al. Cells
- Hippo/YAP Signaling Pathway: A Promising Therapeutic Target in Bone Paediatric Cancers?
- (2020) Sarah Morice et al. Cancers
- Sarcoma treatment in the era of molecular medicine
- (2020) Thomas GP Grünewald et al. EMBO Molecular Medicine
- Analysis of the role of the Hippo pathway in cancer
- (2019) Yanyan Han Journal of Translational Medicine
- Role of the Hippo Pathway in Fibrosis and Cancer
- (2019) Kim et al. Cells
- “Verteporfin exhibits anti-proliferative activity in embryonal and alveolar rhabdomyosarcoma cell lines”
- (2019) Luca Sanna et al. CHEMICO-BIOLOGICAL INTERACTIONS
- The YAP1 signaling inhibitors, verteporfin and CA3, suppress the mesothelioma cancer stem cell phenotype
- (2019) Sivaveera Kandasamy et al. MOLECULAR CANCER RESEARCH
- ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity
- (2019) Cinzia Zucchini et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Oncogenic Signaling Pathways in The Cancer Genome Atlas
- (2018) Francisco Sanchez-Vega et al. CELL
- Understanding osteosarcomas
- (2018) Emily Simpson et al. JAAPA-Journal of the American Academy of Physician Assistants
- The Hippo Signaling Network and its Biological Functions
- (2018) Jyoti R. Misra et al. Annual Review of Genetics
- Repurposing of Drugs Targeting YAP-TEAD Functions
- (2018) Gian Elisi et al. Cancers
- Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970–99: a report from the Childhood Cancer Survivor Study cohort
- (2018) Todd M Gibson et al. LANCET ONCOLOGY
- Whole transcriptome analysis identifies differentially regulated networks between osteosarcoma and normal bone samples
- (2017) Xuan Dung Ho et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Current and future therapeutic approaches for osteosarcoma
- (2017) Douglas J. Harrison et al. Expert Review of Anticancer Therapy
- A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma
- (2017) Shumei Song et al. MOLECULAR CANCER THERAPEUTICS
- Germline and somatic genetics of osteosarcoma — connecting aetiology, biology and therapy
- (2017) D. Matthew Gianferante et al. Nature Reviews Endocrinology
- The Role and Clinical Significance of Yes-Associated Protein 1 in Human Osteosarcoma
- (2017) Y-H. Zhang et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Verteporfin inhibits growth of human glioma in vitro without light activation
- (2017) Ahmad Al-Moujahed et al. Scientific Reports
- YAP/TAZ at the Roots of Cancer
- (2016) Francesca Zanconato et al. CANCER CELL
- Prognostic value of the Hippo pathway transcriptional coactivators YAP/TAZ and β1-integrin in conventional osteosarcoma
- (2016) Corinne Bouvier et al. Oncotarget
- Prognostic factors for survival in patients with high-grade osteosarcoma using the Surveillance, Epidemiology, and End Results (SEER) Program database
- (2015) Kyle R. Duchman et al. Cancer Epidemiology
- Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
- (2015) Fa-Xing Yu et al. CELL
- A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis
- (2015) Toshiro Moroishi et al. GENES & DEVELOPMENT
- Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth
- (2015) Francesca Zanconato et al. NATURE CELL BIOLOGY
- A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas
- (2015) Michael D. Deel et al. Frontiers in Oncology
- Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) ANNALS OF ONCOLOGY
- IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma
- (2013) Marieke L Kuijjer et al. BMC CANCER
- WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition
- (2013) Vickie Y. Jo et al. PATHOLOGY
- Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
- (2012) Y. Liu-Chittenden et al. GENES & DEVELOPMENT
- The Hippo Signaling Pathway in Development and Cancer
- (2010) Duojia Pan DEVELOPMENTAL CELL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started